Overview

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

Status:
Completed
Trial end date:
2015-04-24
Target enrollment:
Participant gender:
Summary
The primary objective is to evaluate in a double-blinded (neither physician nor participant knows the treatment that the participant receives), fashion the taste of different JNJ-53718678 oral liquid formulations as compared to the reference formulation (JNJ-53718678, 10 milligram/milliliter oral solution without sweetener/flavor).
Phase:
Phase 1
Details
Lead Sponsor:
Janssen Sciences Ireland UC